Press releases.

2026202520242023202220212020201920182017201620152014
Aug 20, 2026
News
IR
English
Regulatory
MAR
Report
Interim
Q2
mfn-arc-event
mfn-arc-event-report
Correction: SenzaGen’s interim report January–June 2026 | Continued strong development in Q2 2026 – 13% growth with positive cash flow
Aug 20, 2026
News
IR
English
Regulatory
MAR
Report
Interim
Q2
mfn-arc-event
mfn-arc-event-report
SenzaGen’s interim report January–June 2026 | Continued strong development in Q2 2026 – 13% growth with positive cash flow
Aug 18, 2026
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
Invitation to the presentation of SenzaGen's January-June 2026 interim report
Jun 09, 2026
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
SenzaGen’s subsidiary receives two orders within non-animal testing with a total value of SEK 2.4 million
Jun 05, 2026
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
EU presents roadmap to phase out animal testing – strengthens SenzaGen’s long-term market potential
May 12, 2026
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from AGM of SenzaGen AB on 12 May 2026
May 12, 2026
News
IR
English
Regulatory
MAR
Report
Interim
Q1
SenzaGen’s interim report January–March 2026 | 10% sales growth alongside increased attention to non-animal methods
May 05, 2026
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
Invitation to the presentation of SenzaGen's January-March 2026 interim report
Apr 21, 2026
News
IR
English
Regulatory
Listing Regulation
Report
Annual
SenzaGen’s Annual Report 2025 published
Apr 15, 2026
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
SenzaGen’s subsidiary receives strategically important order
Apr 08, 2026
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
NOTICE OF ANNUAL GENERAL MEETING OF SENZAGEN AB (Publ)
Mar 30, 2026
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
SenzaGen wins new global cosmetics group as customer
Mar 17, 2026
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
SenzaGen to present strong GARD®skin data at the world’s largest toxicology conference together with leading industry partners
Mar 10, 2026
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
Growing interest in non-animal respiratory allergy testing – GARD®air data presented by industry leaders
Feb 13, 2026
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-inside-information
SenzaGen carries out a directed issue of approximately SEK 17.5 million to the institutional investor Eiffel Investment Group
Feb 13, 2026
News
IR
English
Regulatory
MAR
Report
Interim
Yearend
SenzaGen’s Year-End Report 2025 | SenzaGen closes the year with continued strong GARD® sales
Feb 06, 2026
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
Invitation to the presentation of SenzaGen's year-end report 2025
Dec 16, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
SenzaGen further strengthens US market position with 1.5 MSEK order from global chemical industry leader
Nov 20, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
SenzaGen opens expanded laboratory facilities to strengthen capacity in line with 2030 growth plan
Nov 18, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
UK signals shift to non-animal testing – new opportunities for SenzaGen
Next